This week NHS Lothian launched their biggest COVID-19 vaccination centre so far in a bid to deliver more lifesaving vaccinations. The first of thousands of patients have begun streaming through the Lowland Hall at the Royal Highland Centre, Ingliston.
Vaccination teams opened the doors to the huge centre which has 50 vaccination stations with the potential to increase, if required.By opening Lowland Hall, we will be able to more than triple our current capacity.
We will deliver 18,000 vaccines every day as the numbers of patients eligible for the jab increases in line with the population mix in Lothian.
We look forward to welcoming you to the Lowland Hall.
Appealfor those who missed vaccine appointments to come forward
Anyone who was part of vaccine priority groups 1-9 and missed their original appointment is being asked to come forward to arrange their vaccination.
This includes everyone 50 or over, adults on the shielding list, anyone with underlying health conditions, and unpaid carers.
Invitations have been issued to everyone aged 40 or over, with 30-39-year olds starting to be invited now. In the specific areas of Glasgow affected by the current outbreak, all 18-39 year olds are being invited with older age groups first.
Anyone who believes they should have had a letter by now with details of either their first or second dose should call the national helpline or fill out the missing appointments form on the NHS Inform site.
The system for handling missed appointments has recently been streamlined in order to speed up the process.
More than three million people – two thirds of the adult population – have now received their first dose. However, in response to the new variant currently circulating in parts of the UK, and in line with updated JCVI advice, second doses which are not already scheduled, are being brought forward from 12 weeks to eight weeks across Scotland where supply allows.
Chief Medical Officer Dr Gregor Smith said: “Our vaccination programme has been extremely successful, and we’ve seen very high uptake rates across all age groups. However, we know that there will inevitably be a small number of people who, for a variety of reasons, may not have taken up their original appointment.
“Our message to you is clear – it is not too late, and you are still welcome. Please contact us to make an appointment today.
“It continues to be vitally important that everyone takes up the opportunity to get both doses of their vaccination when their opportunity arrives. I want to emphasise that the second dose offers greater and longer lasting protection, and should not be missed.
“Vaccination is crucial in protecting ourselves, our families and communities and helping us on the path back to normality.
“Anyone who missed their original appointment, or thinks they may have been missed, should contact the Vaccination Helpline on 0800 013 8013 or fill out the missing appointment form on the NHS Inform website. They can also help you find other ways to get your coronavirus vaccination if you are unable to leave your home for your appointment on medical grounds.
“People who have been vaccinated should still continue to get tested and engage with contact tracing teams if they are a contact of a positive case. While the latest evidence suggests vaccines provide a high level of protection, they don’t yet provide a guarantee that you can’t still get the virus or pass it on to others around you.”
Vaccine boost for the high street as consumer spending increases across the country – but many big cities continue to lag behind
Consumer spending highest in North and Midlands after restrictions eased last month
But shops, restaurants and pubs in London and other big cities continue to struggle
Government and newly elected metro mayors need a plan to bring visitors back to city centres
April’s lifting of lockdown restrictions provided a much-needed boost to many high streets as spending surged to pre-pandemic levels in more than half of Britain’s cities and large towns – but cities are continuing to struggle.
New data from Centre for Cities’ High Street Recovery Tracker suggests that spending in Britain’s large towns and smaller cities are recovering faster than in its largest urban centres. Northern England and the Midlands is also so far recovering faster than elsewhere – of the 35 places studied where spending has returned to pre-pandemic levels, 20 are in the North and Midlands.
So far, high street spending has recovered the most in Huddersfield, Basildon and Blackburn, while London, Aldershot, Oxford and Birmongham have seen the weakest recoveries in England so far.
Although spending in Scottish cities is the lowest in the UK in April, retail and hospitality opened on a later date than in England.
Cities where spending levels are highest
Rank
City
April 2021 spending (% of pre-lockdown)
Difference to week before reopening (percentage points)
Difference to summer 2020 reopening (percentage points)
1
Huddersfield
119%
48
19
2
Basildon
117%
65
32
3
Blackburn
117%
54
17
4
Birkenhead
117%
80
12
5
Mansfield
117%
77
29
Cities where spending levels are lowest
Rank
City
April 2021 spending (% of pre-lockdown levels)
Difference to week before reopening (percentage points)
Difference to summer 2020 reopening (percentage points)
54
Newcastle
72%
61
32
55
Birmingham
65%
56
28
56
Oxford
62%
45
29
57
Aldershot
56%
15
2
58
London
53%
34
26
59
Dundee
34%
-1
-4
60
Aberdeen
24%
-1
0
61
Glasgow
18%
2
-12
62
Edinburgh
12%
2
4
While high street spending in many larger cities remains below pre-lockdown levels, it is now significantly higher than it was this time last year – suggesting that consumer confidence is returning as more and more people are vaccinated and the pandemic ends.
Despite these positive signs, the Government and England’s newly elected metro mayors must set out plans to encourage people to return to the centres of our largest cities. Without the return of visitors, tourists and office workers thousands of jobs in shops, restaurants, pubs and other city centre services remain under threat.
Centre for Cities’ Chief Executive Andrew Carter said:“We can already see that the vaccination programme and lifting of lockdown is helping businesses get back on their feet. Many cities and towns, particularly those in Northern England and the Midlands, have seen a boom in consumer spending in the past month.
“It’s not all good news, the centres of our biggest cities such as London, Birmingham and Manchester remain quiet as people there continue to work from home. If this doesn’t change in the next few months I’d expect to see more people working in retail and hospitality in our biggest city centres lose their jobs. The Government must work with the newly-elected metro mayors to stop this happening.”
The government’s Vaccines Taskforce has purchased an additional 60 million doses of the Pfizer/BioNTech vaccine
Move will ensure people have the strongest possible protection from COVID-19
An extra 60 million doses of the Pfizer/BioNTech vaccine have been secured by the UK government to help support the booster COVID-19 vaccination programme beginning from the Autumn.
To protect the most vulnerable ahead of the winter, the government is preparing for a booster programme based on clinical need to ensure people have the strongest possible protection against COVID-19.
The additional Pfizer/BioNTech jabs will be used alongside other approved COVID-19 vaccines for the booster programme.
This comes as new data from Public Health England shows that one dose of a COVID-19 vaccine reduces household transmission of the virus by up to half.
Health and Social Care Secretary Matt Hancock said: “Our vaccination programme is bringing back our freedom, but the biggest risk to that progress is the risk posed by a new variant.
“We’re working on our plans for booster shots, which are the best way to keep us safe and free while we get this disease under control across the whole world.
“These further 60 million doses will be used, alongside others, as part of our booster programme from later this year, so we can protect the progress that we’ve all made.”
The government will publish further details on the booster programme in due course and the final policy will be informed by advice from the Joint Committee on Vaccination and Immunisation (JCVI) and the results of clinical trials studying the use of different combinations of approved COVID-19 vaccines.
Vaccines Minister Nadhim Zahawi said: “We are doing everything we can to make sure the most vulnerable are protected from COVID-19 now and in the future.
“Our brilliant Vaccines Taskforce has secured an extra 60 million doses of the Pfizer/BioNTech vaccines to support our booster programme, which will be developed in line with the advice of our experts.
“In the meantime, we are making great progress with our vaccination rollout and I urge everybody to get their vaccines as soon as they are eligible.”
Overall, the UK has secured access to 517 million doses of eight of the most promising COVID-19 vaccines. These are:
Pfizer/BioNTech for 100 million doses – including the additional 60 million doses
Oxford/AstraZeneca for 100 million doses
Moderna for 17 million doses
Janssen for 30 million doses
Novavax for 60 million doses
Valneva for 100 million doses
GlaxoSmithKline and Sanofi Pasteur for 60 million doses
CureVac for 50 million doses
Health services across the UK have now administered a total of 47,540,984 million vaccines between 8 December and 27 April, including 33,959,908 million people with their first dose (64.5% of all adults) and 13,581,076 million with their second (25.8% of all adults).
All vaccines being used in the UK have met the independent Medicines and Healthcare products Regulatory Agency’s (MHRA) strict standards of safety, effectiveness and quality.
Rolling reviews are underway by the MHRA to assess the Janssen and Novavax vaccines. Clinical trials are ongoing for the Valneva, GSK and Sanofi and CureVac jabs.
The UK government has already hit its target of offering everybody in cohorts 1 to 9 – those aged 50 and over, the clinically vulnerable and health and social care workers – a first dose of the vaccine by 15 April and remains on track to offer a jab to all adults by the end of July.
Data from the ONS and Oxford University shows that COVID-19 infections fell significantly by 65% after the first dose of the Oxford/AstraZeneca or Pfizer/BioNTech vaccines, rising further after the second dose.
Data from Public Health England’s real-world study shows the vaccines are already having a significant impact in the UK, reducing hospitalisations and deaths, saving more than 10,000 lives between December and March.
A recent survey published by ONS showed that 92% of those who had been vaccinated with a first dose did not experience any difficulties when going to get their vaccine – such as difficulty travelling to the vaccination site, concerns over catching the virus while there or having a long wait for their appointment.
Vaccines are available from thousands of NHS vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England and vaccinations are taking place at sites including mosques, community centres and football stadiums.
Ben Osborn, Country Manager at Pfizer UK, said: “By more than doubling our supply commitment to the UK, we are delighted to support the ongoing rollout of the UK immunisation programme and help the government in its efforts to address the pandemic.
“Along with our partner BioNTech, we are working relentlessly to support vaccination campaigns worldwide and, based on current projections, believe we can deliver more than 2.5 billion doses of our vaccine globally by the end of 2021.”
The latest UK-wide vaccination statistics are published here
The UK Government has published a series of photographs taken by photojournalists working with the NHS, showcasing the people behind the ‘UK-wide vaccination programme’ – but none of them are from Scotland.
Working with the NHS, photojournalists have captured the monumental collective effort of the largest vaccination programme in British history in a series of poignant, never-before-seen photographs
Images show intimate moments across the UK, including in Salisbury Cathedral, the Royal Welsh Showground in mid-Wales and on Rathlin Island in Northern Ireland
The new photo montage comes as over 45.5 million jabs in total have been administered across the UK in over 2,800 vaccination sites
From care homes to cathedrals and museums to stadiums, photojournalists Jude Palmer, Glenn Edward and Liam McBurney toured the UK over the past few months capturing intimate moments during the monumental national effort to vaccinate the British population and end the (coronavirus) COVID-19 pandemic.
A series of unseen photographs capturing the size and scale of the UK-wide vaccination programme have been published by the UK government ahead of a new campaign urging under-50s to get the jab.
Health and Social Care Secretary Matt Hancock said: “These incredible photographs show the heroic efforts of thousands of vaccinators and volunteers in every corner of the UK who have given so much to protect the most vulnerable in our society against this cruel virus.
“While there is much to celebrate with over 45 million COVID-19 vaccine doses administered so far, the battle is not yet over. I urge everyone to do their bit – when you get the call, get the jab.”
Photographs include smiling portraits of vaccinators and volunteers, a bird’s eye view of socially distanced patients awaiting their jabs in Salisbury Cathedral, and an elderly couple holding hands at a vaccination site in Ulverston, Cumbria.
Jude Palmer, photojournalist, said: “While the pandemic has been an incredibly difficult time in our history, it had to be documented. It’s been an honour to witness the incredible roll out of the life-saving vaccine first-hand and document this in a meaningful, compassionate way.
“The photography project tells many genuine stories of people involved in the vaccine programme and those that have come forward to have their vaccine already – from their smiles, laughs, nerves, and sighs of relief as we get one step closer to a more normal way of life.”
The UK Government has already hit its target of offering everybody in cohorts 1 to 9 – those aged 50 and over, the clinically vulnerable and health and social care workers – and is on track to offer a jab to all adults in the UK by the end of July.
Over 33.5 million people have now received a first dose of a vaccine – over 63.5% of the UK adult population – with 12 million receiving their second dose. This means over 22.8% of the UK adult population have now received both doses of a vaccine – giving them the strongest possible protection from this virus, with over 45.5 million vaccines administered overall.
Throughout February and March, Palmer, Edward and McBurney visited the Science Museum in London, Salisbury Cathedral, the Royal Welsh Showground in mid-Wales (above) and Rathlin Island in Northern Ireland, as well as hospitals, mobile vaccination units, care homes and pop-up vaccination sites.
These never-before-seen images, which illustrate the monumental and collective effort of NHS teams, volunteers and members of the public, have been compiled into a video montage to mark the success of the vaccine programme to date.
They provide an opportunity for people to look back on the programme, reflecting on the heroic efforts to protect those most vulnerable to COVID-19 and look ahead to the second phase of the vaccination programme, which will see all adults offered a first dose by the end of July.
A major new campaign marking the second phase of the national vaccination rollout will be launched today to encourage people aged 50 and under to get their jab when their turn comes.
Alice Tooley, 25, a Volunteer Service Co-Ordinator at refugee charity RETAS in Leeds, who is featured in the photography (above) said: “I was invited to get the vaccine because of my frontline work with vulnerable adults.
“Getting the vaccine was important to me as it meant I could continue my work with asylum seekers and refugees feeling confidence that I wasn’t putting them or myself at risk of the virus.
“As younger people my age get called for theirs, I hope they jump at it the way I did so, as a collective, we all play our part in getting back to a more normal way of life.”
Dr Gavin Chestnutt, 42, GP Partner at Ballycastle Medical Practice and part-time farmer, is seen vaccinating a 92 year-old man in his front garden overlooking the Rathlin Island coastline, Northern Ireland (above).
He said: “It’s been a real honour to play such a central part in the vaccine roll out programme and witness people’s physical relief as they get their first and second jabs. To save elderly people travelling to the clinic through snow and frosty conditions, I’ve been travelling round on boats and by car to reach the most remote corners of Northern Ireland.”
“Most overwhelming has been to see how grateful everyone has been for getting their vaccine and finally seeing some light at the end of the tunnel.”
Just to compensate for the lack of Scottish content, here are a just a few from Greater Glasgow and Clyde! – Ed.
More than 10 million people in the UK vaccinated with a second dose of a COVID-19 jag
Almost one in five adults in the UK have now received both doses
People urged to take up their second doses to maximise protection
Over 10 million people in the UK have received their second dose of a COVID-19 vaccine.
Health services across the UK have now administered a total of 43,084,487 million vaccines between 8 December and 18 April, including 32,932,448 million people with their first dose and 10,152,039 million with their second.
The milestone means over 19% of all UK adults have received both vaccines.
Prime Minister Boris Johnson said: “Vaccines offer us the best possible protection from the virus, so it is fantastic that 10 million people have now received their second dose.
This is another remarkable milestone in our vaccination programme, which has already saved thousands of lives.
“I want to thank the brilliant staff and volunteers involved in the rollout, and urge all those who are called to keep coming forward.”
Health and Social Care Secretary Matt Hancock said: “This is another terrific milestone, meaning over ten million people who are the most vulnerable to COVID in the UK now have double protection from this awful virus.
“Second doses are crucial to maximising the strength and duration of your protection from COVID-19 and I’m urging everybody eligible to get their jab as soon as possible.
“This milestone is thanks to the dedication and tireless efforts of our NHS workers, volunteers, civil servants and everybody working on the frontline to save lives and stop this virus in its tracks.”
The government has already hit its target of offering everybody in cohorts 1 to 9 – those aged 50 and over, the clinically vulnerable and health and social care workers – a first dose of the vaccine by 15 April and remains on track to offer a jab to all adults by the end of July.
Vaccine Minister Nadhim Zahawi said: “Vaccines have already saved more than 10,000 lives and they are the best way to protect you and your loved ones from this dreadful disease.
“We want to send this virus into retreat. No matter who you are, where you live, your race or your religion, I encourage everyone to get both doses when offered and help this country return life to normal.”
All vaccines being used in the UK have undergone robust clinical trials and have met the independent Medicines and Healthcare products Regulatory Agency’s strict standards of safety, effectiveness and quality. Rolling reviews are underway by the MHRA to assess the Janssen and Novavax vaccines.
The speed and breadth of the UK vaccination programme means even more people will soon develop strong protection from serious illness from COVID-19 infection, saving countless lives and significantly reducing pressure on the NHS.
Data from Public Health England’s real-world study shows the vaccines are already having a significant impact in the UK, reducing hospitalisations and deaths, saving more than 10,000 lives between December and March.
Approved vaccines are available from thousands of NHS vaccine centres, GP practices and pharmacies. Around 98% of people live within 10 miles of a vaccination centre in England and vaccinations are taking place at sites including mosques, community centres and football stadiums.
The latest UK-wide vaccination statistics are published here.
PHE’s real-world data on the efficacy of Covid-19 vaccines is available here.
Through the government’s Vaccines Taskforce, the UK has secured early access to 457 million doses of eight of the most promising vaccine candidates, including:
BioNTech/Pfizer for 40 million doses
Oxford/AstraZeneca for 100 million doses
Moderna for 17 million doses
Janssen for 30 million doses
Novavax for 60 million doses
Valneva for 100 million doses
GlaxoSmithKline and Sanofi Pasteur for 60 million doses
CureVac for 50 million doses
To date, the government has invested over £300 million into manufacturing a successful vaccine to enable a rapid roll out.
The UK government is committed to supporting equitable access to vaccines worldwide. The UK is the largest donor to the COVAX facility, the global mechanism to help developing countries access a coronavirus vaccine, and has committed £548 million in UK aid to help distribute 1.3 billion doses of coronavirus vaccines to 92 developing countries this year.
The report explores the key barriers and enablers to accessing the COVID-19 vaccine and how the vaccine delivery model can be improved to reduce inequalities and provide holistic support to those who need it the most.
The key messages from the report are that our health system has a clear moral and human rights duty to those vulnerable groups who fall through the gaps of public service provision to ensure that they are not failed by this crucially important public health intervention.
Some of the key demographics highlighted within the research are at very high risk if they do contract COVID-19, including people who are homeless, prisoners, people living in poverty, people who abuse drugs and alcohol, black and ethnic minority groups, gypsy travellers, refugees and asylum seekers.
The report calls against viewing the Covid-19 vaccine programme as a silo: the programme has to be part of a whole-system, preventative approach to public health and to health inequalities. This requires a joined up suite of interventions that not only help people access the vaccine but supports them to stay well afterwards and enables them to adhere to the Covid-19 regulations safely.
There are a number of recommendations calling for improvements in the communications relating to the COVID-19 vaccine, a need to prioritise collection and analysis of local data about uptake of Covid-19 vaccine by different communities and groups as well as the need to conduct active research into the ongoing vaccination programme.
The report also recommends developing a rolling programme of outreach vaccination clinics, services and events as well as provision of accessible, affordable transport to vaccine centres and clinics.
Finally, the report highlights the importance of involving third sector and community partners in the planning, communications and delivery of public health interventions that could help prevent, mitigate and reduce health inequalities.
The findings of the report will be shared with Scottish Government, Public Health Scotland, NHS Boards as well as a range of key stakeholders across the third sector.
A joint statement from the 4 UK health ministers on JCVI advice for phase 2 of the COVID-19 vaccination programme
The independent Joint Committee on Vaccination and Immunisation (JCVI) has today published its final advice for phase 2 of the COVID-19 vaccination programme, setting out that the most effective way to minimise hospitalisations and deaths is to continue to prioritise people by age.
In line with its interim advice, the JCVI has recommended an age-based approach with adults aged 18 to 49 prioritised in descending age order as follows:
all those aged 40 to 49 years
all those aged 30 to 39 years
all those aged 18 to 29 years
In addition, data indicates that in individuals aged 18 to 49 years there is an increased risk of hospitalisation in males, those who are in certain black, Asian or ethnic minority (BAME) communities, those with a BMI of 30 or more (obese/morbidly obese), and those experiencing socio-economic deprivation.
JCVI strongly advises that individuals in these groups promptly take up the offer of vaccination when they are offered, and that deployment teams should utilise the experience and understanding of local health systems and demographics, combined with clear communications and outreach activity to promote vaccination in these groups.
Individuals who are at increased risk of severe outcomes from COVID-19 are likely to be vaccinated most rapidly by an operationally simple vaccine strategy. JCVI will continue close monitoring of the programme in terms of safety, effectiveness and uptake, and will update its advice as required.
All 4 UK nations have agreed to follow the JCVI’s recommended approach, with the understanding that age is assessed to be the strongest factor linked to mortality, morbidity and hospitalisations, and because speed of delivery is crucial as we provide more people with protection from COVID-19 across the UK.
The UK remains on course to meet the target to offer a vaccine to all those in the phase 1 priority groups by mid-April, and all adults by the end of July.
The UK-wide agreement to follow the prioritisation advice of the JCVI for phase 1 of the vaccine deployment has allowed a consistent rollout of vaccines across the UK, and seamless coordination between England, Northern Ireland, Scotland and Wales.
Signed:
Matt Hancock, Secretary of State, Department of Health and Social Care
Robin Swann, Minister of Health, Northern Ireland Executive
Vaughan Gething, Minister for Health and Social Services, Welsh Government
Jeane Freeman, Cabinet Secretary for Health and Sport, Scottish Government
All adults over 50, the clinically vulnerable and health and social care workers have now been offered a life-saving Covid-19 jab, as the UK Government prepares to move into the next phase of the Covid-19 vaccination programme.
The target was reached ahead of schedule, with the government having pledged to offer a first dose to priority cohorts 1-9 by 15 April.
Nearly 40 million vaccines have now been given in total, with adults under 50 expected to begin to be invited in the coming days.
Prime Minister Boris Johnson said: “We have now passed another hugely significant milestone in our vaccine programme by offering jabs to everyone in the nine highest risk groups.
“That means more than 32 million people have been given the precious protection vaccines provide against Covid-19.
“I want to thank everyone involved in the vaccine rollout which has already saved many thousands of lives.
We will now move forward with completing essential second doses and making progress towards our target of offering all adults a vaccine by the end of July.”
The JCVI are expected to publish their final advice on how the government should vaccinate those aged under 50. This advice will pave the way for the next phase of the vaccination programme, which is expected to begin this week.
NHS organisations in the four nations, in collaboration with devolved administrations, will decide how to operationalise that JCVI advice.
It is thought that people in England in their late 40s will be the first to be invited to book their jabs.
Over 7 million second doses have now been given – with a record 475,230 given on Saturday – and we remain on track to offer a first vaccine to all adults by 31 July.
A UK Government spokesperson said: “The Oxford/AstraZeneca vaccine is safe, effective and has already saved thousands of lives.
“As the MHRA – the UK’s independent regulator – and the JCVI have said, the benefits of the vaccine far outweigh the risks for the vast majority of adults.
“Everybody who has already had a first dose of the AstraZeneca vaccine should receive a second dose of the same brand, irrespective of age, except for the very small number of people who experienced blood clots with low platelet counts from their first vaccination.
“The government will follow today’s updated advice, which sets out that, as a precaution, it is preferable for people under the age of 30 with no underlying health conditions to be offered an alternative vaccine where possible once they are eligible.
“When people are called forward, they should get their jab. Vaccines are the best way out of this pandemic and provide strong protection against Covid-19.
“We are very grateful for the work of our world-leading regulator and our expert advisors as they continue to address this issue.
“More than 37 million jabs overall have already been administered, and we are on track to offer jabs to all over 50s by 15 April and all adults by the end of July.”
